Multi-omics profiling identifies a CXCL9-PD-1 + CD8 + T cell axis for prediction of checkpoint inhibitor pneumonitis
Background Checkpoint inhibitor pneumonitis (CIP) is a life-threatening complication of immune checkpoint inhibitors (ICI). We aimed to identify predictive biomarkers associated with symptomatic CIP (sCIP) and unravel the underlying pathogenesis. Methods We integrated CyTOF, proteomics, single-cell RNA and V(D)J sequencing, single-cell secretomics, and spatial transcriptomics. These techniques were used to profile peripheral blood, bronchoalveolar lavage fluid, and lung tissue samples from two prospective multi-center cohorts of NSCLC patients receiving ICI combination treatments. Results Elevated serum CXCL9 levels combined with high frequencies of peripheral PD-1 + CD8 + T cells after induction ICI were associated with subsequent sCIP (AUC=0.954) and inferior overall survival (HR=7.19, p=0.004). Mechanistically, PD-1 + CD8 + T cells displayed a type 1 effector profile characterized by IFN-γ and MIP-1β secretion. CXCL9/CXCR3 signaling was associated with recruitment of these cells to inflamed lung tissue. Conclusions The CXCL9-PD-1 + CD8 + T cell axis is associated with CIP pathogenesis. This mechanism supports a potential blood-based biomarker model for CIP risk stratification and identifies a promising preventive therapeutic target to optimize clinical management.
Authors
- Q. Zhang
- Zhenting Liu
- Xiaoxiang Zhou (ORCID: https://orcid.org/0000-0002-9077-4215)
- Guowei Cheng
- Linfang Wu (ORCID: https://orcid.org/0000-0001-7654-4627)
- Minghao Wang (ORCID: https://orcid.org/0000-0003-1922-0786)
- Dingrong Zhong (ORCID: https://orcid.org/0000-0002-6229-1830)
- G. Xi
- Nan Bi (ORCID: https://orcid.org/0000-0001-7201-2930)
- Tao Zhang (ORCID: https://orcid.org/0000-0002-8157-7674)
- Jingbo Wang (ORCID: https://orcid.org/0000-0002-5233-5211)
- Shixuan Liu (ORCID: https://orcid.org/0000-0002-9686-2398)
- Chengyi Zhang
- Yin Yang
- Ziming Jiang
- Yibo Gao
- JiaMing Xie
- ying Jiang
- Huiming Yu
- Sijin Sun
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- China-Japan Friendship Hospital (CN)
- National Cancer Center (US)
- Peking University Cancer Hospital (CN)
- Cancer Hospital of Huanxing Chaoyang District Beijing (CN)
- Cancer Hospital of Chinese Academy of Medical Sciences (CN)
Publication Details
- Journal
- European Respiratory Journal
- Published
- 2026-11-19
- DOI
- https://doi.org/10.1183/13993003.00523-2026
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00